U.S. Personal Products Stock News

NYSE:TRGP
NYSE:TRGPOil and Gas

The Bull Case For Targa Resources (TRGP) Could Change Following Record 2025 Earnings And 25% Dividend Hike

Targa Resources Corp. recently reported 2025 results showing revenue of US$17.03 billion and net income of US$1.92 billion, while also outlining extensive new gas processing and NGL infrastructure projects across the Permian and Gulf Coast that are scheduled to come online through 2028. The company coupled this with a planned 25% increase in its 2026 annual common dividend per share to US$5.00, underpinned by record volumes, expanding processing and fractionation capacity, and ongoing share...
NasdaqGS:POOL
NasdaqGS:POOLRetail Distributors

Assessing Pool Corporation (POOL) Valuation After Recent Share Price Moves

Pool (POOL) has attracted investor attention after recent share price moves, with the stock showing a 1 day gain of 1.49% but negative returns over the past week and month. See our latest analysis for Pool. That 1 day share price gain sits against weaker momentum, with a 7 day share price return of 16.63% and a 30 day share price return of 16.38%. The 1 year total shareholder return of 34.66% and 5 year total shareholder return of 29.70% point to sustained pressure rather than a recent...
NYSE:BXMT
NYSE:BXMTMortgage REITs

A Look At Blackstone Mortgage Trust (BXMT) Valuation After CFO Change Earnings Rebound And Completed Buyback

Blackstone Mortgage Trust (BXMT) just paired a change in its finance leadership with fresh earnings and a completed share repurchase program, giving investors several new data points to assess the stock’s risk and income profile. See our latest analysis for Blackstone Mortgage Trust. At a share price of $19.52, Blackstone Mortgage Trust has seen a 1-day share price return of 1.24%, a 30-day share price return of 2.52%, and a 1-year total shareholder return of 5.28%. These developments around...
NasdaqGS:MDGL
NasdaqGS:MDGLBiotechs

A Look At Madrigal Pharmaceuticals (MDGL) Valuation After Rezdiffra’s First Full Year Near US$1b In Sales

Madrigal Pharmaceuticals (MDGL) is back in focus after reporting full-year 2025 results, combining nearly US$1 billion in Rezdiffra sales with a net loss of US$288.28 million and an improving per-share loss. See our latest analysis for Madrigal Pharmaceuticals. The recent full year 2025 update comes after a sharp pullback in the share price, with a 30 day share price return of 9.46% and a 90 day share price return of a 26.52% decline. However, longer term total shareholder returns of 35.04%...
NasdaqGS:EXE
NasdaqGS:EXEOil and Gas

How Investors May Respond To Expand Energy (EXE) Earnings, Capital Returns, and Strategic Shift to Houston

Expand Energy Corporation recently reported past fourth-quarter and full-year 2025 results, with revenue of US$3,272 million and US$12.12 billion respectively, net income of US$553 million and US$1.82 billion, strong earnings per share, and production of about 7.40 Bcfe/d in the quarter and 7.18 Bcfe/d for the year. The company also issued 2026 production guidance of roughly 7.5 Bcfe/d, affirmed its US$0.575 per-share base dividend for March 2026, completed a US$99.99 million buyback...
NYSE:NVT
NYSE:NVTElectrical

nVent Elevates Supply Chain Role To Support Growth And Data Centers

nVent Electric (NYSE:NVT) appointed Mellinda Devese as Executive Vice President and Chief Supply Chain Officer. Devese joins nVent from GE HealthCare, where she held multiple global supply chain leadership roles. Her appointment signals an increased focus on supply chain performance across nVent’s global operations. nVent Electric, listed on the NYSE under ticker NVT, focuses on electrical connection and protection solutions across industrial, commercial, and infrastructure markets. Supply...
NYSE:IHS
NYSE:IHSTelecom

IHS Holding Buyout Reshapes Valuation, Ownership And Regional Tower Exposure

IHS Holding (NYSE:IHS) has agreed to be acquired by MTN Group in an all cash transaction. The deal will take IHS private and is expected to result in its delisting from the NYSE. IHS is also exiting Latin America through the sale of its tower operations in the region to Macquarie Asset Management. These moves collectively reshape the company’s ownership structure, business model, and geographic footprint. IHS Holding runs telecom tower infrastructure, which is central to mobile connectivity...
NYSE:GBX
NYSE:GBXMachinery

A Look At Greenbrier Companies (GBX) Valuation As Weak Demand And Cash Flow Concerns Pressure The Story

Recent commentary on Greenbrier Companies (GBX) has focused on two years of declining unit sales, tighter supply chain competition, high production costs that have compressed gross margins to 14%, and negative free cash flow that has heightened investor scrutiny. See our latest analysis for Greenbrier Companies. Against those headwinds, the share price has shown strong momentum, with a 16.21% 1 month share price return, a 36.01% 3 month share price return, and a 106.10% 3 year total...
NYSE:AGM
NYSE:AGMDiversified Financial

Is Federal Agricultural Mortgage (AGM) Attractive After A 26% One-Year Share Price Slide

If you are wondering whether Federal Agricultural Mortgage is starting to look like value after its recent pullback, this article will walk through what the current share price might be implying about the company. The stock last closed at US$149.46, with a 14.1% decline over 7 days, a 12.7% decline over 30 days, a 15.3% decline year to date, and a 25.8% decline over the past year, while the 3 year and 5 year returns sit at 15.9% and 103.1% respectively. Recent coverage has focused on how...
NYSE:KSS
NYSE:KSSMultiline Retail

A Look At Kohl's (KSS) Valuation After Recent Share Price Weakness

Kohl's (KSS) is back in focus after recent trading left the share price at US$18.78, with a 1-day return of a 2.49% decline and a 7-day return of a 5.39% decline. See our latest analysis for Kohl's. While the recent 7 day share price return of a 5.39% decline, alongside a 1 day drop and year to date weakness, points to fading short term momentum, the 90 day share price return of 19.39% and 1 year total shareholder return of 62.92% show a very different longer term picture that investors are...
NYSE:WELL
NYSE:WELLHealth Care REITs

Is It Too Late To Consider Welltower (WELL) After A 43% One Year Surge?

Many investors are asking whether Welltower's current share price is aligned with its underlying value, or whether expectations have moved ahead of the fundamentals. The stock last closed at US$208.19, with a 1 year return of 42.6% and a 3 year return that is very large at around triple the starting point. This kind of performance can change how the market views both its growth potential and its risk profile. Recent headlines around Welltower have focused on portfolio activity, capital...
NasdaqCM:VKTX
NasdaqCM:VKTXBiotechs

Viking Therapeutics (VKTX) Valuation In Focus As VK2735 Advances In GLP 1 Weight Loss Trials

Viking Therapeutics (VKTX) is back in focus after reporting a full year 2025 net loss of US$359.64 million and a wider basic loss per share, while advancing weight loss candidate VK2735 through late stage trials. See our latest analysis for Viking Therapeutics. At a share price of US$31.03, Viking Therapeutics has a 7 day share price return of 7.00%, while the 90 day share price return of 12.49% and year to date share price return of 12.39% suggest momentum has cooled compared with its very...
NYSE:GXO
NYSE:GXOLogistics

Is It Too Late To Consider GXO Logistics (GXO) After Its 67% One Year Rally?

Wondering if GXO Logistics is still good value after its recent run, or if you might be late to the story? This article is aimed squarely at that question. The share price recently closed at US$65.59, with returns of 0.1% over 7 days, 14.2% over 30 days, 20.8% year to date, and 66.9% over the past year. These figures naturally raise questions about growth potential and changing risk perceptions. Recent coverage has focused on GXO Logistics' position in outsourced logistics and warehouse...
NYSE:UHS
NYSE:UHSHealthcare

Universal Health Services Earnings Beat Highlights Valuation Gap And Outlook Shift

Universal Health Services (NYSE:UHS) reported quarterly earnings that surpassed Wall Street expectations. Results were supported by a recent Medicaid reimbursement and steady demand across its facilities. Management raised its revenue outlook for 2025 following the reimbursement and stronger operating trends. For investors watching NYSE:UHS, the latest update comes with the stock trading around $230.49 and a 1 year return of 28.6%. Over 3 years the stock has returned 59.1%, and over 5 years...
NasdaqGS:EXEL
NasdaqGS:EXELBiotechs

A Look At Exelixis (EXEL) Valuation As Shares Trade Near Narrative Fair Value Estimate

What Exelixis Stock’s Recent Moves May Be Telling Investors Exelixis (EXEL) has been relatively steady overall, with a small 1 day decline of about 1.2% and a 7 day move of roughly 0.7% lower, while the past 3 months show a gain near 3.3%. See our latest analysis for Exelixis. At a share price of US$43.63, Exelixis has seen short term share price momentum soften, yet its 1 year total shareholder return of about 18.4% and 3 year total shareholder return of roughly 1.5x suggest longer term...
NYSE:WAL
NYSE:WALBanks

Huntington Promotion Puts Focus On Western Alliance Association Banking Value

Western Alliance Bancorporation (NYSE:WAL) has promoted Craig Lee Huntington to lead its Association Banking group. Huntington is a founding member of Alliance Association Bank with experience across sales, operations, product, and technology. The promotion highlights the importance of the Association Banking unit within Western Alliance's broader business. The Association Banking group at Western Alliance Bank focuses on serving community associations and related clients, an area that...
NasdaqGS:RXRX
NasdaqGS:RXRXBiotechs

A Look At Recursion Pharmaceuticals (RXRX) Valuation After Nvidia Exit And ARK Invest Share Purchase

Nvidia’s decision to fully exit Recursion Pharmaceuticals (RXRX), followed almost immediately by ARK Invest buying 1.25 million shares, has thrown a spotlight on the stock and its AI-driven drug discovery approach. See our latest analysis for Recursion Pharmaceuticals. Those opposing moves by Nvidia and ARK come after a weak stretch for Recursion, with a 30 day share price return of 27.70% decline and a 1 year total shareholder return of 62.00% decline, pointing to fading momentum despite...
NYSE:GS
NYSE:GSCapital Markets

A Look At Goldman Sachs (GS) Valuation As AI And Governance Moves Shape Investor Optimism

Goldman Sachs Group (GS) has been busy on multiple fronts, pairing fresh fixed income issuance with clear commentary on AI, digital assets, and governance, all of which are influencing how investors are reassessing the stock. See our latest analysis for Goldman Sachs Group. At a share price of US$922.24, Goldman’s recent 1-day, 7-day and 90-day share price returns of 0.61%, 1.89% and 16.63% suggest momentum has been building, while 1-year and 5-year total shareholder returns of 50.43% and...
NYSE:WAB
NYSE:WABMachinery

Wabtec Dellner Deal Expands Passenger Rail And Raises Valuation Questions

Westinghouse Air Brake Technologies (NYSE:WAB) has acquired Dellner Couplers, a specialist in safety critical train connection systems. The deal has been announced and completed, adding Dellner Couplers to Wabtec's passenger rail portfolio. For investors watching NYSE:WAB, this deal comes at a time when the stock is trading at $264.78, with returns of 3.4% over the past week and 15.1% over the past month. The share price performance over longer periods, including 22.4% year to date and...
NYSE:MO
NYSE:MOTobacco

How Altria’s Smoke Free Pivot and 2026 EPS Reaffirmation Will Impact Altria Group (MO) Investors

Earlier in February 2026, Altria Group highlighted at the CAGNY conference its focus on transitioning toward smoke-free offerings, reaffirmed its 2026 adjusted diluted EPS guidance, and outlined ongoing investments in contract manufacturing while managing regulatory headwinds in e-vapor. The company’s emphasis on boosting oral and nicotine pouch revenues, alongside industry progress in curbing illicit trade, is reshaping how investors assess the resilience and evolution of its tobacco...
NYSE:PLD
NYSE:PLDIndustrial REITs

Dividend Hike and Legal Setback Could Be A Game Changer For Prologis (PLD)

Earlier in February 2026, Prologis’ board approved a 6% increase in its annualized dividend to US$4.28 per common share and declared quarterly cash dividends of US$1.07 per common share and US$1.0675 per Series Q preferred share, both payable on March 31, 2026 to holders of record on March 17, 2026. At the same time, Prologis is contending with a large-scale legal verdict in California linked to a 2021 warehouse fire, highlighting both its growing income appeal to shareholders and the legal...
NYSE:FIX
NYSE:FIXConstruction

Is It Too Late To Consider Comfort Systems USA (FIX) After A 303% One Year Surge?

If you are looking at Comfort Systems USA and wondering whether the recent share price really lines up with its underlying worth, you are not alone. The stock last closed at US$1,462.23, with returns of 9.3% over 7 days, 30.4% over 30 days, 45.7% year to date, 303.1% over 1 year, 908.0% over 3 years, and a very large gain over 5 years. These moves have put Comfort Systems USA firmly on the radar for many investors, who are now asking whether the price is still grounded in fundamentals...
NYSE:SEI
NYSE:SEIEnergy Services

Solaris Energy Ties AI Power Deal To New CFO And Capital Choices

Solaris Energy Infrastructure (NYSE:SEI) has signed a ten year equipment rental agreement with an affiliate of a global AI computing leader for power generation supporting data center demand. The company also announced a major finance leadership change, with a new CFO bringing restructuring and sector experience as the outgoing CFO shifts to grow the power solutions segment. Solaris Energy Infrastructure, trading at $49.24, sits at an interesting point after a 39.1% return over the past...
NYSE:ARR
NYSE:ARRMortgage REITs

ARMOUR Residential REIT Q4 Update Highlights Income Potential And Key Risks

ARMOUR Residential REIT (NYSE:ARR) reported robust Q4 2025 results, highlighting portfolio growth and higher book value. The company affirmed its dividend, signaling confidence in the stability of its payout. Management outlined updated plans for capital deployment and risk management in what it views as a supportive market backdrop. The portfolio update included a focus on lower coupon and seasoned mortgage-backed securities to address prepayment risk. ARR also raised fresh capital and...